Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls

被引:17
作者
Lanzo, Erin [1 ]
Monge, Maria [2 ,3 ]
Trent, Maria [4 ,5 ]
机构
[1] Univ Maryland, Sch Med, College Pk, MD USA
[2] Univ Texas Austin, Med, Dell Med Sch, Austin, TX 78712 USA
[3] Univ Texas Austin, Adolescent Med, Dell Med Sch, Austin, TX 78712 USA
[4] Johns Hopkins Sch Med, Pediat, Baltimore, MD 21287 USA
[5] Johns Hopkins Sch Med, Adolescent Med LEAH Fellowship Progams, Baltimore, MD 21287 USA
来源
PEDIATRIC ANNALS | 2015年 / 44卷 / 09期
关键词
LIFE-STYLE MODIFICATION; CYPROTERONE-ACETATE; SYNDROME PCOS; WOMEN; PREVALENCE; SPIRONOLACTONE; SECRETION; METFORMIN; HORMONE; HYPERANDROGENISM;
D O I
10.3928/00904481-20150910-10
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in adolescent girls that has both reproductive and metabolic implications. Patients with PCOS typically present to their pediatrician for evaluation of menstrual irregularity and/or signs of hyperandrogenism, such as hirsutism and acne. The diagnosis of PCOS is made by clinical symptoms and laboratory evaluation. Because of the long-term health consequences that can accompany the disorder, pediatricians should consider PCOS in their initial evaluation of menstrual irregularity. Lifestyle modification is the cornerstone of treatment for girls with PCOS; however, hormonal medication such as oral contraceptive pills and insulin-sensitizing agents are useful and effective adjuncts to therapy. The goals of treatment for girls with PCOS are to improve clinical manifestations of the disorder, health-related quality of life, and long-term health outcomes.
引用
收藏
页码:E223 / E230
页数:8
相关论文
共 53 条
[1]   PREVALENCE OF POLYCYSTIC OVARIES IN WOMEN WITH ANOVULATION AND IDIOPATHIC HIRSUTISM [J].
ADAMS, J ;
POLSON, DW ;
FRANKS, S .
BRITISH MEDICAL JOURNAL, 1986, 293 (6543) :355-359
[2]  
[Anonymous], 2011, INT J PEDIAT ENDOCRI
[3]   ACCELERATED 24-HOUR LUTEINIZING-HORMONE PULSATILE ACTIVITY IN ADOLESCENT GIRLS WITH OVARIAN HYPERANDROGENISM - RELEVANCE TO THE DEVELOPMENTAL PHASE OF POLYCYSTIC OVARIAN SYNDROME [J].
APTER, D ;
BUTZOW, T ;
LAUGHLIN, GA ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :119-125
[4]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[5]   Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[6]   The Use of Lasers in Darker Skin Types [J].
Battle, Eliot F., Jr. ;
Soden, Cylburn E., Jr. .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2009, 28 (02) :130-140
[7]   Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review [J].
Birgisson, Natalia E. ;
Zhao, Qiuhong ;
Secura, Gina M. ;
Madden, Tessa ;
Peipert, Jeffrey F. .
JOURNAL OF WOMENS HEALTH, 2015, 24 (05) :349-353
[8]  
CDC. U.S. Selected Practice Recommendations for Contraceptive Use 2013., 2013, MMWR Recomm. Rep, V62, P1
[9]   Spironolactone for hirsutism in polycystic ovary syndrome [J].
Christy, NA ;
Franks, AS ;
Cross, LB .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) :1517-1521
[10]   Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance [J].
Coviello, AD ;
Legro, RS ;
Dunaif, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) :492-497